The Taxpayers Protection Alliance is a nonprofit advocacy organization focused on government accountability, fiscal responsibility, taxpayer protection, and public policy issues related to spending, regulation, technology, healthcare, and energy.
Coverage areas
Guests (1)
Episodes (2)
2026-05-05
The Taxpayers Protection Alliance’s Ross Marchand Discusses FDA Drug Approval Challenges and Solutionswith Ross Marchand
In the Health Policy Podcast episode featuring Ross Marchand, Executive Director of the Taxpayers Protection Alliance, the discussion centers on the challenges and inefficiencies of the FDA drug approval process. Marchand highlights a report titled "Blocking Breakthroughs," which reveals increasing rejection rates for medications and rising evaluation costs, emphasizing the need for regulatory reforms to improve patient access to life-saving drugs. Recommendations include regulatory reciprocity with international agencies and provisional approvals for medications that meet safety but not efficacy thresholds.
2026-01-21
Taxpayers Protection Alliance Executive Director Ross Marchand Discusses the Flaws of the 340B Drug Pricing Programwith Ross Marchand
In the latest episode of the Health Policy Podcast, Ross Marchand, Executive Director of the Taxpayers Protection Alliance, discusses the flaws of the 340B Drug Pricing Program. He highlights how the program, intended to provide discounted drugs to hospitals, has led to increased costs for taxpayers and patients as hospitals often do not pass on savings. Marchand advocates for reducing government involvement in healthcare to improve cost and quality.
Notable quotes
“Whenever you have these complicated laws and these outta control regulations, everyone loses.”
“What has actually been happening with the 340B program is it's being abused.”
“You have a program that has noble intentions, but is failing because of these unintended consequences.”
“If a program is beyond repair, that is the only solution at the end of the day.”
“Whenever you have all this control and whenever you have all this regulation... the prices are gonna go up and the quality is going to stagnate.”
“The government is far too involved in healthcare, and unless government gets outta the way, costs will continue to climb and quality will continue to stagnate.”
“The FDA is always shifting the goalposts and they are always making up new excuses to deny patients access.”
“Unfortunately, there's a lot of bureaucratic inertia.”